Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Eagle Pharmaceutical (NASDAQ: EGRX)

$90.59 USD $0.07 (0.08%)
Last Price $90.59
Net Change $0.07 (0.08%)
Bid $80
Ask Price $95.88
Open Price $90.82
Previous Close Price $90.52
High Price $91.77
Low Price $90.5
Number of Trades 890
Volume 190,047
Fifty Two Week High $91.77 (2017-04-28)
Fifty Two Week Low $34.2 (2016-06-27)
Average Daily Volume 293,422
Share Outstanding 15,230 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $3.52 (2017-03-01)
2nd Quarter Earnings $0.73 (2016-11-09)
3nd Quarter Earnings $0.8 (2016-08-09)
4th Quarter Earnings $-0.06 (2016-05-09)
PE Ratio $17.93
EPS Growth $-20.36
Recent Earnings $3.52
Annual EPS $4.99
Last Quarter EPS $
Market Capitalization $1.38B
Insider Shareholders % 0.188%
Annual Revenue $0B
No. Shares Outstanding 15,230
Inst. Shareholder % 0%
Annual Net Income $0B
TTM Net Profit Margin $100.79
1-Year Return 130.62%
3-Year Return 816.19%
5-Year Return 605.53%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -20.360001%
Dividends per Share $
Stock Split Ratio
Beta 1.53
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.

No News found for EGRX